Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

378 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antioxidant defense capacity in scleroderma patients.
Sfrent-Cornateanu R, Mihai C, Stoian I, Lixandru D, Bara C, Moldoveanu E. Sfrent-Cornateanu R, et al. Among authors: mihai c. Clin Chem Lab Med. 2008;46(6):836-41. doi: 10.1515/CCLM.2008.132. Clin Chem Lab Med. 2008. PMID: 18601607
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis.
Sobanski V, Giovannelli J, Allanore Y, Riemekasten G, Airò P, Vettori S, Cozzi F, Distler O, Matucci-Cerinic M, Denton C, Launay D, Hachulla E; EUSTAR Collaborators. Sobanski V, et al. Arthritis Rheumatol. 2019 Sep;71(9):1553-1570. doi: 10.1002/art.40906. Epub 2019 Aug 12. Arthritis Rheumatol. 2019. PMID: 30969034 Free PMC article.
Revised European Scleroderma Trials and Research Group Activity Index is the best predictor of short-term severity accrual.
Fasano S, Riccardi A, Messiniti V, Caramaschi P, Rosato E, Maurer B, Smith V, Siegert E, De Langhe E, Riccieri V, Airó P, Mihai C, Avouac J, Zanatta E, Walker UA, Iannone F, García De la Peña Lefebvre P, Distler JHW, Vacca A, Distler O, Kowal-Bielecka O, Allanore Y, Valentini G. Fasano S, et al. Among authors: mihai c. Ann Rheum Dis. 2019 Dec;78(12):1681-1685. doi: 10.1136/annrheumdis-2019-215787. Epub 2019 Aug 17. Ann Rheum Dis. 2019. PMID: 31422354
Intravenous versus oral cyclophosphamide for lung and/or skin fibrosis in systemic sclerosis: an indirect comparison from EUSTAR and randomised controlled trials.
Bruni C, Tashkin DP, Steen V, Allanore Y, Distler O, Grotts J, Matucci-Cerinic M, Furst DE; EUSTAR, SLS I & SLS II centres collaborators. Bruni C, et al. Clin Exp Rheumatol. 2020 May-Jun;38 Suppl 125(3):161-168. Epub 2020 Aug 27. Clin Exp Rheumatol. 2020. PMID: 32865169 Free article. Clinical Trial.
Performance of the UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract 2.0 instrument as a clinical decision aid in the routine clinical care of patients with systemic sclerosis.
Zampatti N, Garaiman A, Jordan S, Dobrota R, Becker MO, Maurer B, Distler O, Mihai C. Zampatti N, et al. Among authors: mihai c. Arthritis Res Ther. 2021 Apr 22;23(1):125. doi: 10.1186/s13075-021-02506-x. Arthritis Res Ther. 2021. PMID: 33888149 Free PMC article.
Digital ulcers predict a worse disease course in patients with systemic sclerosis.
Mihai C, Landewé R, van der Heijde D, Walker UA, Constantin PI, Gherghe AM, Ionescu R, Rednic S, Allanore Y, Avouac J, Czirják L, Hachulla E, Riemekasten G, Cozzi F, Airò P, Cutolo M, Mueller-Ladner U, Matucci-Cerinic M; EUSTAR co-authors. Mihai C, et al. Ann Rheum Dis. 2016 Apr;75(4):681-6. doi: 10.1136/annrheumdis-2014-205897. Epub 2015 Feb 16. Ann Rheum Dis. 2016. PMID: 25688073
378 results